Loading Events

« All Events

  • This event has passed.

2021 Clinical Development Briefing

September 23, 2021



Join us on September 23 at 8:30 a.m. for BioNJ’s Virtual Clinical Development Briefing where we’ll discuss clinical trials in a post-COVID world and what is possible moving forward, how our BioNJ community can help to advance critical improvements and the chance to hear what’s on your mind in a special networking session.


8:30 a.m. –
8:35 a.m.

Welcome & Opening Remarks
Debbie Hart, President & CEO, BioNJ
Angelo Stracquatanio, M.S., CEO & Co-Founder, Apprentice.io
8:35 a.m. –
9:30 a.m.
Shift to Decentralized Trials and the impact on Patients, Physicians and Drug Development
This highly interactive session will feature an EY study of a wide range of 70 companies (CROs, sponsors, technology companies and more) that looked at the impact of COVID-19 on Phase III clinical trials on Patient recruitment, technology, physicians, clinical sites and more and the impact and economic value that could be created from a shift to hybrid or decentralized trials. 
Adam BermanSenior Director, EY Parthenon
Nick Davies, Ph.D.Partner, Life Sciences, Strategy, EY Parthenon
Q&A Moderator: 
Angelo Stracquatanio, M.S., CEO & Co-Founder, Apprentice.io
9:30 a.m. –
10:00 am.
Key Learnings and Actions from the May BioNJ Clinical Development Briefing with Ken Getz
We’ll take a deep dive review of Keynote speaker Ken Getz’s industry landscape highlighting important trends and impacts from COVID-19 inclusive of survey results and break-out session discussions. In addition, the updated 2022 BioNJ Clinical Development Goals will be reviewed, along with opportunities for you to collaborate.
Terese Bandy, Ph.D., M.S., CSSBB, CCRPHead of Operations, Global Medical Capability Development, Sanofi
Patrick Heiser, Ph.D.Associate Vice President, Clinical Development, Ferring Pharmaceuticals
Allison Kinnucan Business Development Manager, Biotrial
10:00 a.m. –
10:30 a.m.
Networking & Closing Remarks
During this facilitated networking session, you will have the opportunity to connect with industry experts to share thoughts and ideas on how to leverage resources in continuing to move the needle forward on this important work.
Registration is $85 for BioNJ Members and $125 for Future Members. We hope you can join us on September 23!

If you would like to join BioNJ, learn about Sponsorship Opportunities or confirm your Membership is up to date in order to ensure that you receive the Member rate, please contact Kim Minton at KMinton@BioNJ.org.

Sponsored by:



September 23, 2021
Event Category: